An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin

Anthony Barnett; M Dreyer; P Lange; M Serdarevic-Pehar

doi:10.2337/dc06-2173

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin

Anthony Barnett, M Dreyer, P Lange, M Serdarevic-Pehar

Birmingham Medical School

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	446-446
Number of pages	1
Journal	Diabetes Care
Volume	30
Issue number	2
DOIs	https://doi.org/10.2337/dc06-2173
Publication status	Published - 1 Feb 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc06-2173

Cite this

@article{431e3cb2466e43829790c94965c55913,

title = "An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin",

author = "Anthony Barnett and M Dreyer and P Lange and M Serdarevic-Pehar",

year = "2007",

month = feb,

day = "1",

doi = "10.2337/dc06-2173",

language = "English",

volume = "30",

pages = "446--446",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "2",

}

An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin. / Barnett, Anthony; Dreyer, M; Lange, P et al.
In: Diabetes Care, Vol. 30, No. 2, 01.02.2007, p. 446-446.

Research output: Contribution to journal › Article

TY - JOUR

T1 - An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin

AU - Barnett, Anthony

AU - Dreyer, M

AU - Lange, P

AU - Serdarevic-Pehar, M

PY - 2007/2/1

Y1 - 2007/2/1

U2 - 10.2337/dc06-2173

DO - 10.2337/dc06-2173

M3 - Article

SN - 0149-5992

VL - 30

SP - 446

EP - 446

JO - Diabetes Care

JF - Diabetes Care

IS - 2

ER -